Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

As Alzheimer's disease progresses beyond the early stages, the behavior changes and emotional impacts of the disease can be ...

A new UVA study finds that HIV drugs like NRTIs may reduce Alzheimer's risk by 10% annually, suggesting potential for repurposing in dementia prevention.

Up to 8 in 10 Americans carry a common viral infection that may raise the risk of developing Alzheimer’s disease, new research suggests.

The U.S. Food and Drug Administration (FDA) has cleared marketing for a new blood test to diagnose Alzheimer's disease in people who are already exhibiting symptoms. This new test is the first ...

An estimated 7.2 million Americans ages 65 and older now have Alzheimer's dementia, up from 6.9 million last year, according to the 2025 Alzheimer's Disease Facts and Figures Report. Nearly three ...

The FDA greenlit marketing for the first blood test to help diagnose Alzheimer’s disease. Experts believe this will increase access to Alzheimer’s detection and reduce reliance on expensive ...

Medications like donanemab (Kisunla) and lecanemab (Leqembi) target amyloid plaques that build up in the brain due to Alzheimer's disease.

As Alzheimer’s disease now affects over seven million Americans, early diagnosis with blood tests and new treatments are gaining support amid rising caregiving costs.

The Alzheimer's Association's latest estimate, released in a report Tuesday, said around 7.2 million in the U.S. have the disease. It's the first time there's been more than 7 million.

A new report shows up to 7.2 million Americans aged 65 and older are living with Alzheimer’s disease, an increase of about 300,000 cases.

The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans and spinal taps to detect the disease.